Literature DB >> 31901550

Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.

Chen Liu1, Xuemei Peng2, Yonghao Li2, Shu Liu2, Rentao Hou2, Yewei Zhang3, Shi Zuo3, Zhan Liu4, Rongcheng Luo5, Libo Li6, Weiyi Fang7.   

Abstract

FAM83A is part of an 8-member protein family of unknown function and is reported to be a cancer-promoting and treatment-resistance factor in several cancers. However, its role in hepatocellular carcinoma (HCC) remains unclear. Analysis of the Cancer Genome Atlas (TCGA) showed that FAM83A mRNA expression is upregulated in HCC, as are the protein expression levels in both HCC cell lines and tissues. Clinical data have demonstrated that high FAM83A expression is positively correlated with poor progression-free survival time, thus suggesting its cancer-promoting potential. Functional analyses showed that FAM83A overexpression promoted HCC cell migration and invasion in vitro and suppressed sorafenib sensitivity. Inhibiting FAM83A reversed these results. A pulmonary metastasis model further confirmed that FAM83A promoted HCC cell metastasis in vivo. Mechanistic analyses indicated that FAM83A activated the PI3K/AKT signaling pathway, its downstream c-JUN protein, and epithelial-to-mesenchymal transition (EMT)-related protein levels, including downregulation of E-cadherin and upregulation of Vimentin and N-cadherin. Interestingly, c-JUN induced FAM83A expression by directly binding to its promoter region and thus forming a positive-feedback loop for FAM83A/PI3K/AKT/c-JUN. In conclusion, we demonstrated that FAM83A, as a cancer-metastasis promoter, accelerates migration, invasion and metastasis by activating the PI3K/AKT/c-JUN pathway and inducing its self-expression via feedback, thus forming a FAM83A/PI3K/AKT/c-JUN positive-feedback loop to activate EMT signaling and finally promote HCC migration, invasion and metastasis.
Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  EMT; FAM83A; HCC; Metastasis; PI3K/AKT

Mesh:

Substances:

Year:  2019        PMID: 31901550     DOI: 10.1016/j.biopha.2019.109780

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

1.  Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis.

Authors:  Shuwei He; Jianzeng Yang; Shitao Jiang; Yuan Li; Xingmin Han
Journal:  Cancer Cell Int       Date:  2020-08-25       Impact factor: 5.722

Review 2.  From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis.

Authors:  Raphael Mohr; Burcin Özdirik; Joeri Lambrecht; Münevver Demir; Johannes Eschrich; Lukas Geisler; Teresa Hellberg; Sven H Loosen; Tom Luedde; Frank Tacke; Linda Hammerich; Christoph Roderburg
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

3.  miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A.

Authors:  Cuiping Liu; Yizhou Jiang; Baosan Han
Journal:  Cancer Manag Res       Date:  2020-12-08       Impact factor: 3.989

4.  Involvement of MicroRNA-1-FAM83A Axis Dysfunction in the Growth and Motility of Lung Cancer Cells.

Authors:  Pei-Jung Liu; Yu-Hsuan Chen; Kuo-Wang Tsai; Hui-Ying Yeah; Chung-Yu Yeh; Ya-Ting Tu; Chih-Yun Yang
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

5.  VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

Authors:  Yingxia Ning; Zhaoyang Zeng; Yuao Deng; Weifeng Feng; Lun Huang; Huiling Liu; Jiazhi Lin; Chen Zhang; Yue Fan; Longyang Liu
Journal:  Cancer Sci       Date:  2021-03-31       Impact factor: 6.716

6.  FAM83A as a Potential Biological Marker Is Regulated by miR-206 to Promote Cervical Cancer Progression Through PI3K/AKT/mTOR Pathway.

Authors:  Li Rong; Haiyu Li; Zhaodong Li; Jing Ouyang; Yongping Ma; Fangzhou Song; Yaokai Chen
Journal:  Front Med (Lausanne)       Date:  2020-12-04

7.  Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer.

Authors:  Junqing Gan; Yanjing Li; Qingwei Meng
Journal:  Front Mol Biosci       Date:  2020-12-10

8.  NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth.

Authors:  Shu Liu; Yewei Zhang; Shien Cui; Dajiang Song; Bo Li; Qian Chen; Guangyu Yao; Bin Gong
Journal:  Cancer Cell Int       Date:  2021-11-13       Impact factor: 5.722

9.  ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis.

Authors:  Rentao Hou; Yonghao Li; Xiaojun Luo; Wan Zhang; Huiling Yang; Yewei Zhang; Jiahao Liu; Shaohua Liu; Siyuan Han; Chen Liu; Yun Huang; Zhen Liu; Aimin Li; Weiyi Fang
Journal:  Int J Biol Sci       Date:  2022-03-21       Impact factor: 6.580

10.  High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.

Authors:  Chengming Tian; Xiyao Li; Chunlin Ge
Journal:  Mol Med       Date:  2021-06-16       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.